Announcement • Feb 13
Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026 Arteris, Inc. provided earnings guidance for the first quarter and full year 2026. For the first quarter, the company expects revenue of $20.5 million to $21.5 million.
For the year, the company expects revenue of $89.0 million to $93.0 million. Announcement • Feb 03
Arteris, Inc. to Report Q4, 2025 Results on Feb 12, 2026 Arteris, Inc. announced that they will report Q4, 2025 results After-Market on Feb 12, 2026 Announcement • Dec 13
Arteris, Inc. (NasdaqGM:AIP) entered into an definitive agreement to acquire Cycuity, Inc. for $45 million. Arteris, Inc. (NasdaqGM:AIP) entered into an definitive agreement to acquire Cycuity, Inc. for $45 million on December 10, 2025. The consideration of $45 million will be paid as $13.5 million in cash and $19.5 million in shares of Arteris's common stock, par value $0.001 per share. The number of shares to be issued will be based on the volume-weighted average price (VWAP) of the Company’s common stock for the 30 consecutive trading days preceding the second trading day prior to the closing date, subject to a collar mechanism. In addition, there is an Earnout Consideration of up to an additional $12 million payable in shares of the Arteris’s common stock (converted at the VWAP), contingent upon Cycuity achieving certain specified bookings milestones for the 2026 calendar year. Arteris has entered into an Open Market Sale Agreement to offer and sell shares of its common stock, with a par value of $0.001 per share, having an aggregate offering price of up to $75 million. The net proceeds, if any, from these offering are intended to be used for general corporate purposes, including acquisitions or other strategic transactions, including acquisition of Cycuity, Inc.
The transaction is subject to the approval of the Merger Agreement by Cycuity’s stockholders and other customary closing conditions. The transaction is expected to close in Arteris’ first quarter of fiscal year 2026.
John M. Tolpa of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP acted as legal advisor for Cycuity, Inc. John A Fisher and Phillip Stoup of Freshfields US LLP acted as legal advisor for Arteris, Inc. Announcement • Dec 12
Arteris, Inc. has filed a Follow-on Equity Offering in the amount of $75 million. Arteris, Inc. has filed a Follow-on Equity Offering in the amount of $75 million.
Security Name: Common Stock
Security Type: Common Stock
Transaction Features: At the Market Offering Announcement • Oct 24
Arteris, Inc. to Report Q3, 2025 Results on Nov 04, 2025 Arteris, Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025 Announcement • Aug 07
Arteris, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2025 Arteris, Inc. provided revenue guidance for the third quarter and full year 2025. For the quarter, the company expects revenue of $16.8 million to $17.2 million.
For the year, the company expects revenue of $66.0 million to $70.0 million. Announcement • Jul 24
Arteris, Inc. to Report Q2, 2025 Results on Aug 05, 2025 Arteris, Inc. announced that they will report Q2, 2025 results on Aug 05, 2025 Announcement • Jun 24
Arteris, Inc. Addresses Silicon Design Reuse Challenge with New Magillem Packaging Product for Ip Blocks and Chiplets Arteris, Inc. announced the immediate availability of Magillem Packaging, a new software product designed to simplify and speed up the process of building advanced chips used in everything from AI data centers to edge devices. As chip design becomes increasingly complex with more components, higher performance demands and tighter timelines, Magillem Packaging helps engineering teams work faster and more efficiently by automating one of the most time-consuming parts of the design process: assembling and reusing existing technology. Magillem Packaging enables IP teams to quickly and reliably package and prepare hundreds or even thousands of components for integration into a chiplet or SoC, including new, existing or third-party IP blocks. Based on the latest version of the IEEE 1685 (IP-XACT) standard, Magillem Packaging works seamlessly with industry tools and silicon IP, helping companies keep up with increasing design demands while reducing costly errors and delays. Key Capabilities of Magillem Packaging from Arteris: IP Reuse with comprehensive IP, subsystem and chiplet packaging in a reusable format including configuration, implementation and verification for incremental and full packaging with a proven methodology. Correct-by-construction IEEE 1685-2022 generation without requiring any pre- requisite IP-XACT expertise, while standard compliance and data consistency are ensured by construction and assessed with a built-in Magillem checkers suite. Scalable and fully automated generation of IP packaging for both reused and new IP blocks, with support for legacy 2009 and 2014 versions of IEEE 1685 standard, with intuitive graphical editors enabling fast viewing and editing of IP block descriptions. The new software builds on Arteris' proven approach to design automation and complements its broader suite of products used by many of the world's top semiconductor companies. Announcement • May 15
Arteris, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2025 Arteris, Inc. provided revenue guidance for the second quarter and full year 2025. For the quarter, the company expects revenue of $16.1 million to $16.5 million.
For the year, the company expects revenue of $65.0 million to $71.0 million. Announcement • Apr 25
Arteris, Inc., Annual General Meeting, Jun 03, 2025 Arteris, Inc., Annual General Meeting, Jun 03, 2025. Announcement • Apr 24
Arteris, Inc. to Report Q1, 2025 Results on May 13, 2025 Arteris, Inc. announced that they will report Q1, 2025 results After-Market on May 13, 2025 Announcement • Feb 26
Arteris, Inc. Releases the Latest Generation of Magillem Registers to Automate Semiconductor Hardware/Software Integration Arteris, Inc. announced the immediate availability of the latest generation of Magillem Registers technology for SoC integration automation. This product enables design teams to automate the hardware/software integration process, reducing the development time by 35% when compared to in-house solutions and empowers them to overcome design complexity challenges, freeing up cycles for new innovation.Magillem Registers is a comprehensive register design and management product that accurately automates the hardware/software interface (HSI) to quickly develop chips and chiplets ranging from IoT devices to complex AI datacenter multi-die SoCs. This product empowers chip architects, hardware designers, firmware engineers, verification teams, and documentation teams to overcome complexity and satisfy the need for real-time, effective cross-functional team communication. It mitigates the risk of out-of-date standards with a unified specification and compilation flow to generate accurate designs. Building upon the silicon-proven Magillem 5 and CSRCompiler technologies, the latest release of Magillem Registers is designed to streamline and optimize workflows by providing an integrated, single source of truth infrastructure to specify, document, implement, and verify SoC address maps. This approach boosts productivity by promoting efficient IP reuse and ensuring consistency across the relevant design teams. With over 1,000 semantic and syntactic checks, Magillem Registers ensures high-quality output, validating third-party IPs, in-house IPs, and overall system integration to significantly reduce the risk of silicon failure. Additionally, intelligent automation enables a remarkable 35%-time reduction in HSI development compared to manual solutions, empowering development teams to meet tight deadlines with confidence. The latest release of Magillem Registers brings significant advancements to performance, capacity, standards support, and usability. It delivers up to 3x faster performance compared to Magillem 5, enabling the compilation of million of registers within minutes while auto-generating synthesizable RTL register banks. With a 5x increase in supported design size, it scales seamlessly from small to very large multi-die devices which contain million of control registers. Magillem Registers offers broad support for industry standards, including the addition of IEEE 1685-2022 (IP-XACT) and SystemRDL 2.0, alongside the previous versions. This enhances intellectual property (IP) reuse, and expands compatibility with third-party IP vendors, improving SoC integration. Usability enhancements further boost team productivity with a rapid, highly iterative design environment incorporating features for streamlined input, intuitive document navigation, customizable workflows, and the elimination of repetitive time-consuming and error-prone manual tasks through advanced automation. Magillem Registers addresses the growing demands of modern design environments with unmatched efficiency and scalability. Announcement • Feb 19
Arteris, Inc. Introduces FlexGen, Revolutionizing Semiconductor Design with Smart Network-on-Chip IP Arteris, Inc. introduced FlexGen, a revolutionary, smart network-on-chip (NoC) interconnect IP. FlexGen from Arteris dramatically accelerates chip development while optimizing performance efficiency, addressing the rising demand for faster, more sustainable innovation in automotive, datacenter, consumer electronics, communications and industrial applications. With up to a 10x productivity boost, FlexGen slashes design iterations, significantly reducing the time required to develop cutting-edge chips. FlexGen also achieves up to a 30% reduction in wire length to lower power use, and up to 10% reduction in latency that results in improved performance in SoC and chiplet designs. FlexGen builds upon the silicon-proven and physically aware FlexNoC 5 NoC IP technology and component library to automate the creation of high-performance network-on-chip (NoC) designs. Supported by AI-driven automation, FlexGen reduces manual adjustments by over 90%, enabling the generation of optimized NoC topologies in hours instead of days. This significantly accelerates development while maintaining the quality achieved through manual methods. These advancements are critical as the industry scales to meet the demands of advanced technologies like artificial intelligence, autonomous driving and cloud computing. By streamlining chip design workflows and automating key processes, FlexGen enables companies to tackle the growing complexity of semiconductor design with fewer resources, paving the way for innovations in AI, 5G, and industrial IoT. With FlexGen, Arteris continues to revolutionize SoC and chiplet design automation based on Arm, RISC-V and x86 processors, enhancing productivity and positioning teams to address the complexities of next-generation electronic systems. Announcement • Feb 03
Arteris, Inc. to Report Q4, 2024 Results on Feb 18, 2025 Arteris, Inc. announced that they will report Q4, 2024 results After-Market on Feb 18, 2025 Announcement • Nov 06
Arteris, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2024 Arteris, Inc. provided revenue guidance for the fourth quarter and full year 2024. For the quarter, the company expects revenue of $14.7 million - $15.7 million.
For the year, the company expects revenue of $56.9 million - $57.9 million. Announcement • Oct 22
Arteris, Inc. to Report Q3, 2024 Results on Nov 05, 2024 Arteris, Inc. announced that they will report Q3, 2024 results After-Market on Nov 05, 2024 Announcement • Oct 16
Arteris Network-on-Chip Tiling Innovation Accelerates Semiconductor Designs for AI Applications Arteris, Inc. announced an innovative evolution of its network-on-chip (NoC) IP products with tiling capabilities and extended mesh topology support for faster development of Artificial Intelligence (AI) and Machine Learning (ML) compute in system-on-chip (SoC) designs. The new functionality enables design teams to scale compute performance by more than 10 times while meeting project schedules plus power, performance and area (PPA) goals. Network-on-chip tiling is an emerging trend in SoC design. The evolutionary approach uses proven, robust network-on-chip IP to facilitate scaling, condense design time, speed testing and reduce design risk. It allows SoC architects to create modular, scalable designs by replicating soft tiles across the chip. Each soft tile represents a self-contained functional unit, enabling faster integration, verification and optimization. Tiling coupled with mesh topologies within Arteris’ NoC IP products, FlexNoC and Ncore, are transformative for the ever-growing inclusion of AI compute into most SoCs. AI-enabled systems are growing in size and complexity yet can be quickly scaled with the addition of soft tiles without disrupting the entire SoC design. Together, the combination of tiling and mesh topologies provides a way to further reduce the auxiliary processing unit (XPU) sub-system design time and overall SoC connectivity execution time by up to 50% versus manually integrated, non-tiled designs. The first iteration of NoC tiling organizes Network Interface Units (NIUs) into modular, repeatable blocks, improving scalability, efficiency and reliability in SoC designs. These SoC designs result in increasingly larger and more advanced AI compute which supports fast-growing, sophisticated AI workloads for Vision, Machine Learning (ML) models, Deep Learning (DL), Natural Language Processing (NLP) including Large Language Models (LLMs), and Generative AI (GAI), both for training and inference, including at the edge. The FlexNoC and Ncore NoC IP products, which offer expanded AI support via tiling and extended mesh topology capabilities, are now available to early-access customers and partners. Announcement • Sep 17
Joachim Kunkel Joins Arteris's Board of Directors Arteris, Inc. announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys’ IP revenue to over $1.5 billion. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where he played a pivotal role in its early success by contributing to engineering, sales and marketing. He holds a master’s degree in electrical engineering from Aachen University of Technology, where he focused his research on system-level simulation techniques for digital signal processing. Announcement • Aug 02
Arteris, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024 Arteris, Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, the company expects revenue of $14.2 million to $15.2 million.
For the year, the company expects revenue of $56.0million to $58.0 million. Announcement • Jul 23
Arteris, Inc. to Report Q2, 2024 Results on Aug 01, 2024 Arteris, Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024 Recent Insider Transactions Derivative • May 06
VP, General Counsel & Secretary exercised options and sold US$66k worth of stock On the 1st of May, Paul Alpern exercised 11k options at a strike price of around US$0.56 and sold these shares for an average price of US$6.38 per share. This trade did not impact their existing holding. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$977k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • May 03
First quarter 2024 earnings: EPS and revenues exceed analyst expectations First quarter 2024 results: US$0.25 loss per share. Revenue: US$12.9m (down 1.6% from 1Q 2023). Net loss: US$9.40m (loss widened 4.4% from 1Q 2023). Revenue exceeded analyst estimates by 2.7%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US. Announcement • May 03
Arteris, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024 Arteris, Inc. provided earnings guidance for the Second Quarter and Full Year 2024. For the quarter, the company expected ACV + TTM royalties to be $58.0 million - $62.0 million. Revenue to be $13.2 million - $14.2 million. For the year, the company expected ACV + TTM royalties to be $62.0 million - $68.0 million. Revenue to be $54.5 million - $57.5 million. Recent Insider Transactions • Apr 07
Chairman recently sold US$71k worth of stock On the 2nd of April, Karel Janac sold around 10k shares on-market at roughly US$7.03 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Karel has been a net seller over the last 12 months, reducing personal holdings by US$106k. Recent Insider Transactions Derivative • Apr 05
VP, General Counsel & Secretary exercised options and sold US$75k worth of stock On the 1st of April, Paul Alpern exercised 11k options at a strike price of around US$0.56 and sold these shares for an average price of US$7.24 per share. This trade did not impact their existing holding. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$764k more than they bought, via options and on-market transactions in the last 12 months. Announcement • Mar 13
Arteris Expands Ncore Cache Coherent Interconnect IP to Accelerate Leading-Edge Electronics Designs Arteris, Inc. announced the immediate availability of the latest release of Ncore cache coherent network-on-chip (NoC) IP. Ncore ensures low latency integration of hardware accelerators into a coherent domain, enabling the speed and efficiency required for cutting-edge applications in complex SoC designs. Deploying Ncore can save SoC design teams upwards of 50 years of engineering effort per project compared to manually generated interconnect solutions. The latest release of Ncore works with multiple processor IPs, including RISC-V and the next-generation Armv9 Cortex processor IP. Ncore boasts multi-protocol support, allowing seamless integration of IPs connected to the same NoC fabric. Designers can choose from CHI-E, CHI-B and ACE fully coherent agent interfaces and ACE-Lite IO-coherent interfaces. AXI is also supported for interfacing with sub-systems or devices without coherency requirements. These capabilities enhance the flexibility and adaptability of Ncore, making it an ideal solution for complex and evolving SoC designs, including safety-critical applications. With configurability and scalability at its core, Ncore empowers SoC designers to meet specific power, performance and area requirements with the flexible fine-tuning of the NoC architecture. Ncore is also ISO 26262 certified, helping design teams address the critical demands of automotive and industrial safety applications with requirements from ASIL B to ASIL D. Ncore's ISO 26262 certification underscores Arteris' ongoing commitment to delivering safe, secure and reliable technology to its global customers. Ncore supports direct connections for heterogeneous, asymmetric systems and other flexible connectivity options, ensuring adaptability to various applications across automotive, industrial, communications and enterprise computing markets. Ncore cache coherent interconnect IP is an ideal companion to FlexNoC, Arteris' industry-leading non-coherent interconnect IP. Recent Insider Transactions Derivative • Mar 08
VP, General Counsel & Secretary notifies of intention to sell stock Paul Alpern intends to sell 12k shares in the next 90 days after lodging an Intent To Sell Form on the 5th of March. If the sale is conducted around the recent share price of US$7.26, it would amount to US$84k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$595k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Feb 22
Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat Full year 2023 results: US$1.03 loss per share (further deteriorated from US$0.84 loss in FY 2022). Revenue: US$53.7m (up 6.5% from FY 2022). Net loss: US$36.9m (loss widened 35% from FY 2022). Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US. Announcement • Feb 21
Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024 Arteris, Inc. provided earnings guidance for the first quarter and full year of 2024. For the quarter, the company expects revenue of $12.1 million to $13.1 million.For the year, the company expects revenue of $54.5 million to $57.5 million. Recent Insider Transactions Derivative • Feb 04
VP, General Counsel & Secretary notifies of intention to sell stock Paul Alpern intends to sell 13k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of February. If the sale is conducted around the recent share price of US$6.19, it would amount to US$82k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$532k more than they bought, via options and on-market transactions in the last 12 months. Board Change • Feb 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. Independent Director Claudia Munce was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Jan 30
Arteris, Inc. to Report Q4, 2023 Results on Feb 20, 2024 Arteris, Inc. announced that they will report Q4, 2023 results After-Market on Feb 20, 2024 Recent Insider Transactions Derivative • Jan 07
VP & CFO notifies of intention to sell stock Nicholas Hawkins intends to sell 32k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of January. If the sale is conducted around the recent share price of US$5.41, it would amount to US$174k. Since March 2023, Nicholas' direct individual holding has decreased from 269.10k shares to 189.10k. Company insiders have collectively sold US$427k more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Dec 07
VP & CFO notifies of intention to sell stock Nicholas Hawkins intends to sell 21k shares in the next 90 days after lodging an Intent To Sell Form on the 5th of December. If the sale is conducted around the recent share price of US$5.40, it would amount to US$112k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 209.10k. Company insiders have collectively sold US$370k more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Nov 26
VP & CFO notifies of intention to sell stock Nicholas Hawkins intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 21st of November. If the sale is conducted around the recent share price of US$4.80, it would amount to US$96k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 229.10k. Company insiders have collectively sold US$313k more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Nov 18
VP, General Counsel & Secretary notifies of intention to sell stock Paul Alpern intends to sell 53k shares in the next 90 days after lodging an Intent To Sell Form on the 15th of November. If the sale is conducted around the recent share price of US$4.86, it would amount to US$258k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 43.07k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Nov 10
Third quarter 2023 earnings: EPS and revenues exceed analyst expectations Third quarter 2023 results: US$0.23 loss per share. Revenue: US$13.3m (up 5.4% from 3Q 2022). Net loss: US$8.15m (loss widened 6.1% from 3Q 2022). Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in the US. Announcement • Nov 09
Arteris, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023 Arteris, Inc. provided revenue guidance for the fourth quarter and full year 2023. For the quarter, the company expected revenue to be in the range of $11.3 million to $12.3 million. For the full year, the company expected revenue to be in the range of $52.5 million to $53.5 million. Price Target Changed • Nov 09
Price target decreased by 18% to US$11.50 Down from US$14.00, the current price target is an average from 6 analysts. New target price is 138% above last closing price of US$4.83. Stock is up 4.5% over the past year. The company is forecast to post a net loss per share of US$1.07 next year compared to a net loss per share of US$0.84 last year. Announcement • Oct 25
Arteris, Inc. to Report Q3, 2023 Results on Nov 07, 2023 Arteris, Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2023 Recent Insider Transactions Derivative • Oct 06
VP & CFO notifies of intention to sell stock Nicholas Hawkins intends to sell 23k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of October. If the sale is conducted around the recent share price of US$6.24, it would amount to US$141k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 249.10k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Sep 11
Chief Operating Officer notifies of intention to sell stock Laurent Moll intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 8th of September. If the sale is conducted around the recent share price of US$7.19, it would amount to US$146k. Since December 2022, Laurent's direct individual holding has increased from 77.29k shares to 185.77k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Aug 04
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2023 results: US$0.26 loss per share (further deteriorated from US$0.18 loss in 2Q 2022). Revenue: US$14.7m (flat on 2Q 2022). Net loss: US$9.17m (loss widened 62% from 2Q 2022). Revenue exceeded analyst estimates by 9.1%. Earnings per share (EPS) missed analyst estimates by 5.4%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in the US. Announcement • Aug 04
Arteris, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2023 Arteris, Inc. provided earnings guidance for the third quarter and full year of 2023. For the quarter, the company expects revenue to be in the range of $12.5 million to $13.5 million.For the full year, the company expects revenue to be in the range of $54.0 million to $56.0 million. Announcement • Jul 23
Arteris, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Arteris, Inc. announced that they will report Q2, 2023 results After-Market on Aug 03, 2023 Recent Insider Transactions Derivative • Jun 12
VP, General Counsel & Secretary notifies of intention to sell stock Paul Alpern intends to sell 42k shares in the next 90 days after lodging an Intent To Sell Form on the 9th of June. If the sale is conducted around the recent share price of US$7.44, it would amount to US$313k. Paul now holds 48.95k shares directly in their own name. Company insiders have collectively bought US$49k more than they sold, via options and on-market transactions, in the last 12 months. Announcement • May 06
Arteris, Inc. Provides Earnings Guidance for the Second Quarter of 2023; Provides Earnings Guidance for the Year 2023 Arteris, Inc. provided earnings guidance for the second quarter of 2023. For the quarter, the company expects revenue of $53.5 million to $57.5 million.For the year, the company expects revenue of $60.4 million to $65.4 million. Reported Earnings • May 06
First quarter 2023 earnings: EPS and revenues exceed analyst expectations First quarter 2023 results: US$0.26 loss per share (further deteriorated from US$0.22 loss in 1Q 2022). Revenue: US$13.2m (up 12% from 1Q 2022). Net loss: US$9.01m (loss widened 32% from 1Q 2022). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) also surpassed analyst estimates by 9.6%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Software industry in the US. Price Target Changed • Mar 14
Price target decreased by 8.1% to US$13.60 Down from US$14.80, the current price target is an average from 5 analysts. New target price is 202% above last closing price of US$4.51. Stock is down 65% over the past year. The company is forecast to post a net loss per share of US$0.93 next year compared to a net loss per share of US$0.84 last year. Major Estimate Revision • Mar 08
Consensus EPS estimates fall by 18% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$64.0m to US$59.2m. Losses expected to increase from US$0.73 per share to US$0.87. Software industry in the US expected to see average net income growth of 11% next year. Consensus price target down from US$14.80 to US$13.60. Share price fell 6.4% to US$5.11 over the past week. Reported Earnings • Mar 01
Full year 2022 earnings released: US$0.84 loss per share (vs US$1.06 loss in FY 2021) Full year 2022 results: US$0.84 loss per share. Revenue: US$50.4m (up 33% from FY 2021). Net loss: US$27.4m (loss widened 17% from FY 2021). Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Software industry in the US.